McKesson (NYSE:MCK) issued an update on its FY19 earnings guidance on Thursday morning. The company provided earnings per share guidance of $13.00-13.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.38.
A number of research analysts have recently commented on the stock. ValuEngine lowered shares of McKesson from a hold rating to a sell rating in a research report on Tuesday. Mizuho set a $186.00 price target on shares of McKesson and gave the company a hold rating in a research report on Wednesday, January 24th. Barclays assumed coverage on shares of McKesson in a research report on Thursday, March 8th. They set an equal weight rating and a $165.00 price target for the company. Zacks Investment Research lowered shares of McKesson from a buy rating to a hold rating in a research report on Monday, February 5th. Finally, Bank of America assumed coverage on shares of McKesson in a research report on Tuesday, February 27th. They set a buy rating and a $179.00 price target for the company. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of $175.53.
McKesson opened at $146.83 on Thursday, Marketbeat reports. McKesson has a 12-month low of $134.25 and a 12-month high of $178.86. The stock has a market capitalization of $30.22 billion, a PE ratio of 12.65, a PEG ratio of 1.34 and a beta of 1.31. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.07 and a quick ratio of 0.61.
McKesson (NYSE:MCK) last announced its quarterly earnings data on Thursday, May 24th. The company reported $3.49 earnings per share for the quarter, missing analysts’ consensus estimates of $3.56 by ($0.07). McKesson had a net margin of 2.34% and a return on equity of 22.98%. The company had revenue of $51.63 billion for the quarter, compared to the consensus estimate of $51.36 billion. During the same quarter in the previous year, the business earned $3.41 EPS. The company’s quarterly revenue was up 6.0% compared to the same quarter last year. research analysts forecast that McKesson will post 12.68 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, July 2nd. Shareholders of record on Friday, June 1st will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.93%. The ex-dividend date of this dividend is Thursday, May 31st. McKesson’s dividend payout ratio (DPR) is 11.71%.
In other McKesson news, SVP Erin M. Lampert sold 1,413 shares of the firm’s stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $149.38, for a total transaction of $211,073.94. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.20% of the company’s stock.
McKesson Company Profile
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.